We are an iconic provider of hospital-based healthcare, striving to deliver an exceptional standard of care
We comprise several hospitals, health centres, a nationally accredited education provider and a world-class research institute
We are a nationally accredited, hospital-based Registered Training Organisation - the only one of its kind in Queensland
We are part of a collaborative research institute with The University of Queensland and founding partner of the Translational Research Institute
The team at Mater Hospital Brisbane's Congenital Cardiology Service understand the concern for many members of our Adult Congenital Heart Disease (ACHD) patient community with regard to COVID-19. We hope the information below is helpful to you at this time.
In line with the latest advice from Queensland Health, from 6 am on Thursday 15 April 2021, visitors are now permitted at all Mater hospitals.
Please visit the individual facility pages for further information on all other Mater hospitals across Queensland.
In line with the updated guidelines from Queensland Health, surgical face masks will no longer be required to be worn by all patients, visitors and staff while within in our facilities.
However, you are encouraged to wear a mask and wear it wherever you cannot socially distance and will be available to anyone entering our hospitals.
We appreciate your support through these changes to keep us all safe.
We do not yet know the answer to this. It is possible that people with ACHD will have the same symptoms as people in the community, meaning that 80% of people will have a very mild and self-limiting illness, and 20% of people will be sicker than this and may require an inpatient hospital admission.
We are concerned about evidence suggesting that COVID-19 may have a more significant impact in patients with cardiovascular comorbidities, however there is no data specific to people with ACHD. Most of the affected patients are older, have hypertension and acquired heart disease—not congenital heart disease.
To date, anecdotal reports suggest there is no significant increase in severity of COVID-19 for patients with ACHD.
If you are worried about your health, your GP is your first point of call. We will continue to be available for support through the Clinical Nurse Consultant Cardiology on 07 31638567, or email email@example.com. Should you be present to another hospital for care please notify us of your admission using these contact details.
For Mater patient and general community updates on COVID-19, click here.
It is normal to have concern and unease about your health during stressful events. The Australian Psychological Society has some suggestions on how to care for yourself and manage this stress, available here.
We will manage ACHD patients who are COVID-19 positive as we would manage those of you who develop other viral illnesses and an increase in symptoms. You may be admitted to hospital and have your medications or antibiotics changed.
At the present time it is very important to be mindful of the risks posed by COVID-19 to people living with ACHD, and for employers to try and place the employee in a work scenario where the risk to exposure is minimised (e.g. deployed to a low traffic/contact area). It is very important to be mindful that some ACHD patients may be at higher risk than others and should work from home if possible.
If you are unsure if you are in this category please contact Mater's ACHD team on 07 31638567.
The majority of patients with ACHD should be able to use public transport by practising the recommended social distancing requirements.
If you are concerned please contact Mater's ACHD team on 07 31638567.
Please refer to the latest information regarding the wearing of masks in our South East Queensland hospitals.
Stay informed and read the latest announcements about COVID-19 and up-to-date advice here.
Thank you for your patience and understanding during this time.